ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

STOK Stoke Therapeutics Inc

13.90
-0.13 (-0.93%)
May 17 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 471,156
Bid Price 13.49
Ask Price 15.00
News (3)
Day High 14.175

Low
3.35

52 Week Range

High
16.3999

Day Low 13.73
Company Name Stock Ticker Symbol Market Type
Stoke Therapeutics Inc STOK NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.13 -0.93% 13.90 20:00:00
Open Price Low Price High Price Close Price Prev Close
14.11 13.73 14.175 13.90 14.03
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
8,860 471,156 $ 13.96 $ 6,577,367 - 3.35 - 16.3999
Last Trade Time Type Quantity Stock Price Currency
16:36:24 16 $ 13.61 USD

Stoke Therapeutics (STOK) Options Flow Summary

Overall Flow

Bullish

Net Premium

70k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

0.00%

Sweeps Ratio

1.00%

Stoke Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
619.79M 44.65M - 8.78M -104.7M -2.34 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Stoke Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No STOK Message Board. Create One! See More Posts on STOK Message Board See More Message Board Posts

Historical STOK Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week12.1414.8011.0113.08836,1061.7614.50%
1 Month11.5514.8010.9012.05818,7552.3520.35%
3 Months5.3016.39995.280611.671,421,3088.60162.26%
6 Months4.1816.39993.7710.76781,5979.72232.54%
1 Year11.2716.39993.359.72548,2042.6323.34%
3 Years35.2941.603.3513.00351,767-21.39-60.61%
5 Years27.2171.583.3517.55279,072-13.31-48.92%

Stoke Therapeutics Description

Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels.

Your Recent History

Delayed Upgrade Clock